Skip to Content

WATSON 415 (Estropipate 1.5 mg)

This pill with imprint "WATSON 415" is Orange, Round and has been identified as Estropipate 1.5 mg. It is manufactured by Watson Pharmaceuticals.

Estropipate is used in the treatment of atrophic urethritis; postmenopausal symptoms; primary ovarian failure; osteoporosis; oophorectomy (and more), and belongs to the drug class estrogens. Not for use in pregnancy. Estropipate 1.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Estropipate 1.5 mg WATSON 415
Estropipate 1.5 mg WATSON 415
Estropipate 1.5 mg WATSON 415  Front
Estropipate 1.5 mg WATSON 415  Back
Estropipate
Imprint:
WATSON 415
Strength:
1.5 mg
Color:
Orange
Shape:
Round
Availability:
Prescription only
Drug Class:
Estrogens
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
Not a controlled drug
Manufacturer:
Watson Pharmaceuticals

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide